CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
Atlanta, Georgia, United States and 223 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
Atlanta, Georgia, United States and 82 other locations
drug LY3484356 alone or in combination with other anticancer therapies is safe and effective in participants with advanced or metastatic breast cancer...
Phase 1
Atlanta, Georgia, United States and 73 other locations
This is a Phase 2, multicenter, two-stage, open-label, parallel-group study designed to evaluate the efficacy and safety of vudalimab (XmAb20717) in...
Phase 2
Atlanta, Georgia, United States and 16 other locations
in participants with platinum-resistant ovarian carcinoma, endometrial adenocarcinoma, and urothelial carcinoma based on Acrivon's OncoSigna...
Phase 1, Phase 2
Atlanta, Georgia, United States and 66 other locations
The purpose of this study is to characterize the safety, tolerability, and efficacy of IDE161 as a single agent and in combination with pembrolizumab.
Phase 1
Atlanta, Georgia, United States and 22 other locations
The purpose of this study is to compare pembrolizumab + adjuvant chemotherapy with placebo + adjuvant chemotherapy, with or without radiotherapy, wit...
Phase 3
Atlanta, Georgia, United States and 230 other locations
-small-cell lung cancer (NSCLC), triple negative breast cancer (TNBC), ovarian cancer (OC), endometrial cancer...
Phase 1, Phase 2
Atlanta, Georgia, United States and 123 other locations
First-in-human, open-label, sequential dose escalation and expansion study of CPI-0209 in patients with advanced solid tumors and lymphomas....
Phase 1, Phase 2
Atlanta, Georgia, United States and 59 other locations
A Study of XMT-1660 in Solid Tumors...
Phase 1
Atlanta, Georgia, United States and 17 other locations
Clinical trials
Research sites
Resources
Legal